• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中间型地中海贫血的自然史。

The natural history of thalassemia intermedia.

机构信息

Department of Clinical and Experimental Medicine, Università di Ferrara, Ferrara, Italy.

出版信息

Ann N Y Acad Sci. 2010 Aug;1202:214-20. doi: 10.1111/j.1749-6632.2010.05550.x.

DOI:10.1111/j.1749-6632.2010.05550.x
PMID:20712795
Abstract

The severity of thalassemia intermedia depends on the degree of imbalance between alpha and non-alpha chains as well as other genetic and environmental factors that modify the natural history of the disease. By definition, the patients spontaneously maintain hemoglobin at or above 7 g/dL, sometimes at the price of intense hyperplasia of the bone marrow that is in turn responsible for bone deformities, osteoporosis, and extramedullary erythropoietic masses that often characterize thalassemia intermedia. Transfusion may become necessary with advancing age, during infection and pregnancy, and when hypersplenism develops. Splenectomy is often needed. Iron overload in nontransfused patients is due to increased gastrointestinal absorption and involves mainly the liver. Complications affecting the lives of patients with thalassemia intermedia include pulmonary hypertension, leg ulcers, pseudoxanthoma elasticum, gallstones, hepatocellular carcinoma, and thromboembolic events.

摘要

中间型地中海贫血的严重程度取决于α和非α链之间的失衡程度,以及其他改变疾病自然史的遗传和环境因素。根据定义,患者的血红蛋白自然维持在 7g/dL 或以上,有时骨髓过度增生,导致骨骼畸形、骨质疏松症和骨髓外红细胞生成肿块,这些都是中间型地中海贫血的特征。随着年龄的增长、感染和怀孕时以及发生脾功能亢进时,可能需要输血。脾切除术通常是必要的。未输血患者的铁过载是由于胃肠道吸收增加引起的,主要涉及肝脏。影响中间型地中海贫血患者生活的并发症包括肺动脉高压、腿部溃疡、弹性假黄瘤、胆结石、肝细胞癌和血栓栓塞事件。

相似文献

1
The natural history of thalassemia intermedia.中间型地中海贫血的自然史。
Ann N Y Acad Sci. 2010 Aug;1202:214-20. doi: 10.1111/j.1749-6632.2010.05550.x.
2
Thalassemia intermedia: revisited.中间型地中海贫血:再探讨
Blood Cells Mol Dis. 2006 Jul-Aug;37(1):12-20. doi: 10.1016/j.bcmd.2006.04.005. Epub 2006 Jun 5.
3
Complications of β-thalassemia intermedia in Iran during 1996-2010 (single-center study).1996 - 2010年伊朗中间型β地中海贫血的并发症(单中心研究)
Pediatr Hematol Oncol. 2011 Sep;28(6):497-508. doi: 10.3109/08880018.2011.572144. Epub 2011 Jul 5.
4
Iron loading and endocrine functions in nontransfused patients with beta-thalassemia intermedia or sickle-cell thalassemia.中间型β地中海贫血或镰状细胞性地中海贫血非输血患者的铁负荷与内分泌功能
Isr J Med Sci. 1981 Jan;17(1):22-7.
5
Detection of the cardiovascular complications of thalassemia by echocardiography.超声心动图检测地中海贫血的心血管并发症。
Ann N Y Acad Sci. 2010 Aug;1202:165-72. doi: 10.1111/j.1749-6632.2010.05643.x.
6
Pseudoxanthoma-elasticum-like syndrome and thalassemia: an update.弹性假黄瘤样综合征与地中海贫血:最新进展
Dermatol Online J. 2009 Jul 15;15(7):7.
7
Modern treatment of thalassaemia intermedia.中间型地中海贫血的现代治疗
Br J Haematol. 2007 Aug;138(3):291-304. doi: 10.1111/j.1365-2141.2007.06654.x. Epub 2007 Jun 12.
8
[Thalassemia intermedia: 36 cases].
Tunis Med. 2010 Feb;88(2):102-4.
9
β-thalassemia intermedia: a clinical perspective.中间型β-地中海贫血:临床视角。
Cold Spring Harb Perspect Med. 2012 Jul;2(7):a013482. doi: 10.1101/cshperspect.a013482.
10
Pathophysiology of beta thalassaemia.β地中海贫血的病理生理学
Pediatr Endocrinol Rev. 2011 Mar;8 Suppl 2:263-70.

引用本文的文献

1
Magnitude of Bone Disease in Transfusion-Dependent and Non-Transfusion-Dependent β-Thalassemia Patients.输血依赖型和非输血依赖型β地中海贫血患者的骨病严重程度
Cureus. 2024 Mar 12;16(3):e56012. doi: 10.7759/cureus.56012. eCollection 2024 Mar.
2
Fertility preservation for pediatric patients with hemoglobinopathies: Multidisciplinary counseling needed to optimize outcomes.儿科血红蛋白病患者的生育力保存:需要多学科咨询以优化结局。
Front Endocrinol (Lausanne). 2022 Oct 24;13:985525. doi: 10.3389/fendo.2022.985525. eCollection 2022.
3
Non-Transfusion-Dependent Thalassemia: A Panoramic Review.
非输血依赖型地中海贫血症:全景综述。
Medicina (Kaunas). 2022 Oct 21;58(10):1496. doi: 10.3390/medicina58101496.
4
Molecular Characterization and Disease-Related Morbidities of β-Thalassemia Patients from the Northeastern Part of Iraq.伊拉克东北部β地中海贫血患者的分子特征及疾病相关并发症
Int J Gen Med. 2020 Dec 9;13:1453-1467. doi: 10.2147/IJGM.S277947. eCollection 2020.
5
Beta-Thalassemia Intermedia: A Single Thalassemia Center Experience from Northeastern Iraq.中间型β-地中海贫血:来自伊拉克东北部的单一地中海贫血中心经验。
Biomed Res Int. 2020 Feb 28;2020:2807120. doi: 10.1155/2020/2807120. eCollection 2020.
6
Whole-exome sequencing indicates 2 variant associated with leg ulcers in Brazilian sickle cell anemia patients.全外显子组测序提示 2 种变异与巴西镰状细胞贫血患者的腿部溃疡相关。
Exp Biol Med (Maywood). 2019 Aug;244(11):932-939. doi: 10.1177/1535370219849592. Epub 2019 May 12.
7
Prepubertal Hypertransfusion in Thalassemia Intermedia: A Case Report of Sustained Positive Effects on Growth, Splenic Function and Endocrine Parameters.中间型地中海贫血青春期前大量输血:对生长、脾功能和内分泌参数持续产生积极影响的病例报告
Oman Med J. 2012 Nov;27(6):e012. doi: 10.5001/omj.2012.125.
8
Current and future alternative therapies for beta-thalassemia major.重型β地中海贫血的现有及未来替代疗法
Biomed J. 2016 Feb;39(1):24-38. doi: 10.1016/j.bj.2015.10.001. Epub 2016 Apr 6.
9
Prevalence and Risk Factors for Complications in Patients with Nontransfusion Dependent Alpha- and Beta-Thalassemia.非输血依赖型α和β地中海贫血患者并发症的患病率及危险因素
Anemia. 2015;2015:793025. doi: 10.1155/2015/793025. Epub 2015 Nov 18.
10
Identification and key management of non-transfusion-dependent thalassaemia patients: not a rare but potentially under-recognised condition.非输血依赖型地中海贫血患者的识别与关键管理:并非罕见但可能未得到充分认识的病症。
Orphanet J Rare Dis. 2014 Sep 30;9:131. doi: 10.1186/s13023-014-0131-7.